The biggest COVID-19 news in cardiology, all in one place

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

Cardiac injury is common among patients hospitalized with COVID-19, according to new research out of Wuhan, China. The study, published in JAMA Cardiology, also found that cardiac injuries were associated with an increased risk of in-hospital mortality.

The American Heart Association (AHA) has shared new recommendations for providing emergency cardiovascular care, including CPR, to patients with known or suspected COVID-19.

Hypertensive patients may be at a greater risk of dying from COVID-19, the viral disease stemming from the world’s largest coronavirus outbreak to date, according to Bloomberg News.

Patients with cardiovascular disease should continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) as prescribed if they are diagnosed with the new coronavirus (COVID-19), according to a joint statement from three medical societies. 

A cardiologist in the Philippines, described by his peers as “one of the great pillars of cardiology,” has died after working around the clock to treat COVID-19 patients.

A cardiologist in London has attracted significant media attention after reportedly selling at-home testing kits for the new coronavirus for more than $400—and racking up considerable profits.

The American Heart Association (AHA) has shared a detailed account of its role as the world continues to fight against the spread of the new coronavirus.

Just days before the American College of Cardiology canceled its annual scientific sessions for the first time in the meeting’s 69-year history, it released a set of guidelines for cardiology care teams dealing with the COVID-19 outbreak.

The Montreal Heart Institute has launched a new clinical trial aimed at improving care for patients who have been diagnosed with COVID-19.

The American Heart Association (AHA) has set aside $2.5 million to fund cardiovascular and cerebrovascular research into the new coronavirus.

Of COVID-19 patients who develop serious heart complications, most don’t see this problem until late in the disease’s progression. However, some are turning up with extensive heart inflammation at the outset.

Efforts to limit the spread of the new coronavirus have made all of us extra cautious about germs and familiar with the concept of social distancing—but that doesn’t mean all exercise has to be put on hold.

Cardiovascular care professionals must consider the concerns and views of healthcare workers, members of hospital/health system leadership and, not least, patients—whether the latter are infected with COVID-19 or not.

The British Heart Foundation (BHF) has published a statement warning patients with certain medical conditions, including cardiovascular diseases, to be “extra vigilant” as the new coronavirus continues to spread.